Mark L. Smythe
Chief Executive Officer bij Infensa Bioscience Pty Ltd.
Profiel
Mark L.
Smythe is the founder of Protagonist Therapeutics, Inc. which was founded in 2006.
He held the title of Vice President-Technology from 2013 to 2022.
Currently, he is the Chief Executive Officer at Infensa Bioscience Pty Ltd.
since 2022.
He previously worked at GSK Plc as a Principal.
Dr. Smythe obtained a doctorate from the University of Melbourne and an undergraduate degree from James Cook University.
Actieve functies van Mark L. Smythe
| Bedrijven | Functie | Begin |
|---|---|---|
| Infensa Bioscience Pty Ltd. | Chief Executive Officer | 01-05-2022 |
Eerdere bekende functies van Mark L. Smythe
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Founder | 01-05-2022 |
| GSK PLC | Corporate Officer/Principal | - |
Opleiding van Mark L. Smythe
| University of Melbourne | Doctorate Degree |
| James Cook University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GSK PLC | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
| Infensa Bioscience Pty Ltd. |
